Targeting SARS-CoV-2 RNA-dependent RNA polymerase may provide useful information for drug development or repurposing against COVID-19.
can provide useful information for drug development or drug repurposing to combat SARS-CoV-2 as well as future pandemics.
No takes yet. Share an insight, caveat, or question.
Vicenti et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: